Thomas F. Gajewski to Hematologic Neoplasms
This is a "connection" page, showing publications Thomas F. Gajewski has written about Hematologic Neoplasms.
Connection Strength
0.186
-
Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignancies. J Clin Oncol. 2004 Dec 01; 22(23):4816-22.
Score: 0.186
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.